Cargando…

A Phase I trial of B-cell depletion with anti-CD20 monoclonal antibody (rituximab) in the treatment of systemic lupus erythematosus

Detalles Bibliográficos
Autores principales: Eisenberg, R, Albert, D, Stansberry, J, Tsai, D, Kolasinski, S, Khan, S
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833820/
http://dx.doi.org/10.1186/ar830
_version_ 1782178476338446336
author Eisenberg, R
Albert, D
Stansberry, J
Tsai, D
Kolasinski, S
Khan, S
author_facet Eisenberg, R
Albert, D
Stansberry, J
Tsai, D
Kolasinski, S
Khan, S
author_sort Eisenberg, R
collection PubMed
description
format Text
id pubmed-2833820
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28338202010-03-08 A Phase I trial of B-cell depletion with anti-CD20 monoclonal antibody (rituximab) in the treatment of systemic lupus erythematosus Eisenberg, R Albert, D Stansberry, J Tsai, D Kolasinski, S Khan, S Arthritis Res Ther Oral Presentation BioMed Central 2003 2003-09-12 /pmc/articles/PMC2833820/ http://dx.doi.org/10.1186/ar830 Text en
spellingShingle Oral Presentation
Eisenberg, R
Albert, D
Stansberry, J
Tsai, D
Kolasinski, S
Khan, S
A Phase I trial of B-cell depletion with anti-CD20 monoclonal antibody (rituximab) in the treatment of systemic lupus erythematosus
title A Phase I trial of B-cell depletion with anti-CD20 monoclonal antibody (rituximab) in the treatment of systemic lupus erythematosus
title_full A Phase I trial of B-cell depletion with anti-CD20 monoclonal antibody (rituximab) in the treatment of systemic lupus erythematosus
title_fullStr A Phase I trial of B-cell depletion with anti-CD20 monoclonal antibody (rituximab) in the treatment of systemic lupus erythematosus
title_full_unstemmed A Phase I trial of B-cell depletion with anti-CD20 monoclonal antibody (rituximab) in the treatment of systemic lupus erythematosus
title_short A Phase I trial of B-cell depletion with anti-CD20 monoclonal antibody (rituximab) in the treatment of systemic lupus erythematosus
title_sort phase i trial of b-cell depletion with anti-cd20 monoclonal antibody (rituximab) in the treatment of systemic lupus erythematosus
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833820/
http://dx.doi.org/10.1186/ar830
work_keys_str_mv AT eisenbergr aphaseitrialofbcelldepletionwithanticd20monoclonalantibodyrituximabinthetreatmentofsystemiclupuserythematosus
AT albertd aphaseitrialofbcelldepletionwithanticd20monoclonalantibodyrituximabinthetreatmentofsystemiclupuserythematosus
AT stansberryj aphaseitrialofbcelldepletionwithanticd20monoclonalantibodyrituximabinthetreatmentofsystemiclupuserythematosus
AT tsaid aphaseitrialofbcelldepletionwithanticd20monoclonalantibodyrituximabinthetreatmentofsystemiclupuserythematosus
AT kolasinskis aphaseitrialofbcelldepletionwithanticd20monoclonalantibodyrituximabinthetreatmentofsystemiclupuserythematosus
AT khans aphaseitrialofbcelldepletionwithanticd20monoclonalantibodyrituximabinthetreatmentofsystemiclupuserythematosus
AT eisenbergr phaseitrialofbcelldepletionwithanticd20monoclonalantibodyrituximabinthetreatmentofsystemiclupuserythematosus
AT albertd phaseitrialofbcelldepletionwithanticd20monoclonalantibodyrituximabinthetreatmentofsystemiclupuserythematosus
AT stansberryj phaseitrialofbcelldepletionwithanticd20monoclonalantibodyrituximabinthetreatmentofsystemiclupuserythematosus
AT tsaid phaseitrialofbcelldepletionwithanticd20monoclonalantibodyrituximabinthetreatmentofsystemiclupuserythematosus
AT kolasinskis phaseitrialofbcelldepletionwithanticd20monoclonalantibodyrituximabinthetreatmentofsystemiclupuserythematosus
AT khans phaseitrialofbcelldepletionwithanticd20monoclonalantibodyrituximabinthetreatmentofsystemiclupuserythematosus